Cargando…
The clinicopathological features of ganglioglioma with CD34 expression and BRAF mutation in patients with epilepsy
OBJECTIVE: The aim of the study was to evaluate the clinicopathological features, as well as the surgical prognosis, of epilepsy-associated gangliogliomas (GG) with CD34 expression and BRAF(V600E) mutation. METHODS: Clinical data of patients who underwent epilepsy surgery for GG were retrospectively...
Autores principales: | Xie, Ming-Guo, Wang, Xiong-Fei, Qiao, Jiao, Zhou, Jian, Guan, Yu-Guang, Li, Tian-Fu, Qi, Xue-Ling, Luan, Guo-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995901/ https://www.ncbi.nlm.nih.gov/pubmed/36910263 http://dx.doi.org/10.3389/fnmol.2023.1022364 |
Ejemplares similares
-
Novel Perspectives Regarding CD34 Immunoexpression Patterns in Gangliogliomas
por: LISIEVICI, ANTONIA CARMEN, et al.
Publicado: (2021) -
Seizure outcomes and prognostic factors in patients with gangliogliomas associated with epilepsy
por: Hu, Yue, et al.
Publicado: (2022) -
Novel BRAF alteration in desmoplastic infantile ganglioglioma with response to targeted therapy
por: Blessing, Melissa M., et al.
Publicado: (2018) -
Treatment of BRAF V600E mutated ganglioglioma of the third ventricle with dabrafenib
por: Kilmister, Ethan John, et al.
Publicado: (2021) -
The long‐term surgical outcomes of low‐grade epilepsy‐associated neuroepithelial tumors
por: Xie, Ming‐Guo, et al.
Publicado: (2022)